China Biologic Reports Financial Results for the Second Quarter of 2017

CHINA BIOLOGIC PRODUCTS, INC. AND SUBSIDIARIES

RECONCILIATION OF NON-GAAP FINANCIAL MEASURES 

For the Three Months Ended

June 30, 

June 30, 

2017

2016

USD

USD

Adjusted Net Income Attributable to the Company - Non GAAP

38,506,047

35,167,523

Diluted EPS - Non GAAP

1.35

1.26

Non-cash employee stock compensation

(7,475,563)

(4,414,488)

Net Income Attributable to the Company

31,030,484

30,753,035

Weighted average number of shares used in computation of Non GAAP diluted EPS

27,478,935

27,152,560

For the Six Months Ended

June 30, 

June 30, 

2017

2016

USD

USD

Adjusted Net Income Attributable to the Company - Non GAAP

75,936,135

65,609,897

Diluted EPS - Non GAAP

2.67

2.36

Non-cash employee stock compensation

(14,913,802)

(8,659,607)

Net Income Attributable to the Company

61,022,333

56,950,290

Weighted average number of shares used in computation of Non GAAP diluted EPS

27,472,301

27,145,470